
OrthoPediatrics (KIDS) Stock Forecast & Price Target
OrthoPediatrics (KIDS) Analyst Ratings
Bulls say
OrthoPediatrics is experiencing a "Super Cycle" of new product launches, leading to strong sales growth and taking market share from competitors. The company has a strong position in the pediatric orthopedic market and a targeted focus on the needs of pediatric patients, setting it apart from larger competitors who have passed on this market opportunity. The company's success in developing and launching new products has been bolstered by a concentrated pipeline and high support from key opinion leaders. With a strong product pipeline and increasing profitability, the company is well-positioned for continued growth and potential multiple expansion.
Bears say
OrthoPediatrics is a young and innovative company, founded in 2006 and focused exclusively on pediatric orthopedics. However, risks to the company's stock and rating include competition from larger, more established orthopedic companies, potential slowdowns in product development, and potential staffing shortages and turnover at customer sites. Furthermore, the company's current portfolio of 46 surgical systems may face competition from larger competitors, which could affect sales and profitability in the future.
This aggregate rating is based on analysts' research of OrthoPediatrics and is not a guaranteed prediction by Public.com or investment advice.
OrthoPediatrics (KIDS) Analyst Forecast & Price Prediction
Start investing in OrthoPediatrics (KIDS)
Order type
Buy in
Order amount
Est. shares
0 shares